{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:53:26Z","timestamp":1788994406914,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["92149304"],"award-info":[{"award-number":["92149304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82030034"],"award-info":[{"award-number":["82030034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anhui Provincial Key R&D Project","award":["202304295107020059"],"award-info":[{"award-number":["202304295107020059"]}]},{"name":"Natural Sciences Foundation of Anhui Province","award":["1908085QH321"],"award-info":[{"award-number":["1908085QH321"]}]},{"name":"Chinese Academy of Science","award":["XDB39000000"],"award-info":[{"award-number":["XDB39000000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01644-z","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T06:48:29Z","timestamp":1734763709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Brain derived \u03b2-interferon is a potential player in Alzheimer\u2019s disease pathogenesis and cognitive impairment"],"prefix":"10.1186","volume":"16","author":[{"given":"Qiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duntao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"2","key":"1644_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"G Collaborators","year":"2022","unstructured":"Collaborators GF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8.","journal-title":"Lancet Public Health"},{"issue":"10284","key":"1644_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, Cummings J. Flier Alzheimer\u2019s disease Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4. van der.","journal-title":"Flier Alzheimer\u2019s disease Lancet"},{"issue":"4","key":"1644_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","journal-title":"Lancet Neurol"},{"issue":"7973","key":"1644_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gluck S, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620(7973):374\u201380. https:\/\/doi.org\/10.1038\/s41586-023-06373-1.","journal-title":"Nature"},{"issue":"2","key":"1644_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J. Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5xFAD mice. Nat Aging. 2023;3(2):202\u201312. https:\/\/doi.org\/10.1038\/s43587-022-00337-2.","journal-title":"Nat Aging"},{"issue":"5","key":"1644_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","volume":"26","author":"JC Udeochu","year":"2023","unstructured":"Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, et al. Gan. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023;26(5):737\u201350. https:\/\/doi.org\/10.1038\/s41593-023-01315-6.","journal-title":"Nat Neurosci"},{"key":"1644_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbi.2021.08.234","volume":"98","author":"L Dai","year":"2021","unstructured":"Dai L, Wang Q, Lv X, Gao F, Chen Z, Shen Y. Elevated beta-secretase 1 expression mediates CD4(+) T cell dysfunction via PGE2 signalling in Alzheimer\u2019s disease. Brain Behav Immun. 2021;98:337\u201348. https:\/\/doi.org\/10.1016\/j.bbi.2021.08.234.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1644_CR8","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/jci133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020;130(4):1912\u201330. https:\/\/doi.org\/10.1172\/jci133737.","journal-title":"J Clin Invest"},{"key":"1644_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-023-01315-6","author":"JC Udeochu","year":"2023","unstructured":"Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, et al. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023. https:\/\/doi.org\/10.1038\/s41593-023-01315-6.","journal-title":"Nat Neurosci"},{"key":"1644_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.03.018","author":"ER Roy","year":"2022","unstructured":"Roy ER, Chiu G, Li S, Propson NE, Kanchi R, Wang B, Coarfa C, Zheng H. Cao. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid beta plaques. Immunity. 2022. https:\/\/doi.org\/10.1016\/j.immuni.2022.03.018.","journal-title":"Immunity"},{"issue":"7831","key":"1644_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","volume":"586","author":"JY Hur","year":"2020","unstructured":"Hur JY, Frost GR, Wu X, Crump C, Pan SJ, Wong E, et al. The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer\u2019s disease. Nature. 2020;586(7831):735\u201340. https:\/\/doi.org\/10.1038\/s41586-020-2681-2.","journal-title":"Nature"},{"issue":"12","key":"1644_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2007","unstructured":"Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR. Stark. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975\u201390. https:\/\/doi.org\/10.1038\/nrd2422.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"1644_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"FJ Barrat","year":"2019","unstructured":"Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20(12):1574\u201383. https:\/\/doi.org\/10.1038\/s41590-019-0466-2.","journal-title":"Nat Immunol"},{"issue":"4","key":"1644_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41590-019-0323-3","volume":"20","author":"P Hubel","year":"2019","unstructured":"Hubel P, Urban C, Bergant V, Schneider WM, Knauer B, Stukalov A, et al. A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat Immunol. 2019;20(4):493\u2013502. https:\/\/doi.org\/10.1038\/s41590-019-0323-3.","journal-title":"Nat Immunol"},{"key":"1644_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513\u201345. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120231.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1644_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50(4):907\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.025.","journal-title":"Immunity"},{"issue":"1","key":"1644_CR17","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1038\/s41598-020-59917-0","volume":"10","author":"Z Moore","year":"2020","unstructured":"Moore Z, Mobilio F, Walker FR, Taylor JM, Crack PJ. Abrogation of type-I interferon signalling alters the microglial response to A\u03b2(1\u201342). Sci Rep. 2020;10(1):3153. https:\/\/doi.org\/10.1038\/s41598-020-59917-0.","journal-title":"Sci Rep"},{"issue":"1","key":"1644_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-016-0341-4","volume":"4","author":"MR Minter","year":"2016","unstructured":"Minter MR, Moore Z, Zhang M, Brody KM, Jones NC, Shultz SR, et al. Deletion of the type-1 interferon receptor in APPSWE\/PS1\u2206E9 mice preserves cognitive function and alters glial phenotype. Acta Neuropathol Commun. 2016;4(1):72. https:\/\/doi.org\/10.1186\/s40478-016-0341-4.","journal-title":"Acta Neuropathol Commun"},{"key":"1644_CR19","doi-asserted-by":"publisher","first-page":"105272doi","DOI":"10.1016\/j.nbd.2021.105272","volume":"152","author":"F Xue","year":"2021","unstructured":"Xue F, Tian J, Yu C, Du H, Guo L. Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer\u2019s pathology in 5\u00d7FAD mice. Neurobiol Dis. 2021;152:105272doi. https:\/\/doi.org\/10.1016\/j.nbd.2021.105272.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1644_CR20","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1016\/j.neurobiolaging.2015.04.018","volume":"36","author":"RS Jones","year":"2015","unstructured":"Jones RS, Minogue AM, Fitzpatrick O, Lynch MA. Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP\/PS1 mice. Neurobiol Aging. 2015;36(10):2716\u201324. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.018.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1644_CR21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","volume":"170","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol. 2007;170(2):680\u201392. https:\/\/doi.org\/10.2353\/ajpath.2007.060378.","journal-title":"Am J Pathol"},{"issue":"5","key":"1644_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.neurobiolaging.2013.10.089","volume":"35","author":"JM Taylor","year":"2014","unstructured":"Taylor JM, Minter MR, Newman AG, Zhang M, Adlard PA, Crack PJ. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(5):1012\u201323. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.10.089.","journal-title":"Neurobiol Aging"},{"key":"1644_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-015-0263-2","volume":"12","author":"MR Minter","year":"2015","unstructured":"Minter MR, Main BS, Brody KM, Zhang M, Taylor JM, Crack PJ. Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro. J Neuroinflammation. 2015;12:71. https:\/\/doi.org\/10.1186\/s12974-015-0263-2.","journal-title":"J Neuroinflammation"},{"issue":"47","key":"1644_CR24","doi-asserted-by":"publisher","first-page":"49523","DOI":"10.1074\/jbc.M402034200","volume":"279","author":"YF Liao","year":"2004","unstructured":"Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004;279(47):49523\u201332. https:\/\/doi.org\/10.1074\/jbc.M402034200.","journal-title":"J Biol Chem"},{"issue":"6205","key":"1644_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","volume":"346","author":"K Baruch","year":"2014","unstructured":"Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346(6205):89\u201393. https:\/\/doi.org\/10.1126\/science.1252945.","journal-title":"Science"},{"key":"1644_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbi.2015.06.008","volume":"49","author":"SD Mesquita","year":"2015","unstructured":"Mesquita SD, Ferreira AC, Gao F, Coppola G, Geschwind DH, Sousa JC, et al. The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer\u2019s disease. Brain Behav Immun. 2015;49:280\u201392. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.008.","journal-title":"Brain Behav Immun"},{"key":"1644_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05788-0","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023. https:\/\/doi.org\/10.1038\/s41586-023-05788-0.","journal-title":"Nature"},{"key":"1644_CR28","doi-asserted-by":"publisher","unstructured":"Gao F, Lv X, Dai L, Wang Q, Wang P, Cheng Z, et al. A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer\u2019s dementia: China Aging and Neurodegenerative Initiative (CANDI) study. Alzheimer\u2019s & Dementia; 2022. https:\/\/doi.org\/10.1002\/alz.12700.","DOI":"10.1002\/alz.12700"},{"issue":"4","key":"1644_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al Contributors, NIA-AA Research Framework. Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1644_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","volume":"11","author":"SE O\u2019Bryant","year":"2015","unstructured":"O\u2019Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, et al. and B.w. groups. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research. Alzheimers Dement. 2015;11(5):549\u201360. https:\/\/doi.org\/10.1016\/j.jalz.2014.08.099.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1644_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"7","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, et al. The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement. 2011;7(4):386\u201395. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2243.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1644_CR32","doi-asserted-by":"publisher","first-page":"109393","DOI":"10.1016\/j.celrep.2021.109393","volume":"36","author":"JC Nawroth","year":"2021","unstructured":"Nawroth JC, Petropolis DB, Manatakis DV, Maulana TI, Burchett G, Schlunder K, et al. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Rep. 2021;36(3):109393. https:\/\/doi.org\/10.1016\/j.celrep.2021.109393.","journal-title":"Cell Rep"},{"issue":"3","key":"1644_CR33","doi-asserted-by":"publisher","first-page":"e53302","DOI":"10.15252\/embr.202153302","volume":"23","author":"N Zeng","year":"2022","unstructured":"Zeng N, Capelle CM, Baron A, Kobayashi T, Cire S, Tslaf V, et al. DJ-1 depletion prevents immunoaging in T-cell compartments. EMBO Rep. 2022;23(3):e53302. https:\/\/doi.org\/10.15252\/embr.202153302.","journal-title":"EMBO Rep"},{"key":"1644_CR34","doi-asserted-by":"publisher","first-page":"102032doi","DOI":"10.1016\/j.pneurobio.2021.102032","volume":"202","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, Xia Y, Liu P, Liu X, Edgington-Mitchell L, Lei K, Yu SP, Wang XC, Ye K. ApoE4 activates C\/EBPbeta\/delta-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol. 2021;202:102032doi. https:\/\/doi.org\/10.1016\/j.pneurobio.2021.102032.","journal-title":"Prog Neurobiol"},{"key":"1644_CR35","doi-asserted-by":"publisher","first-page":"18003doi","DOI":"10.1038\/nrdp.2018.3","volume":"4","author":"WM van der Flier","year":"2018","unstructured":"van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH. Scheltens. Vascular cognitive impairment. Nat Rev Dis Primers. 2018;4:18003doi. https:\/\/doi.org\/10.1038\/nrdp.2018.3.","journal-title":"Nat Rev Dis Primers"},{"key":"1644_CR36","doi-asserted-by":"publisher","first-page":"1051177","DOI":"10.3389\/fnagi.2023.1051177","volume":"15","author":"L Tan","year":"2023","unstructured":"Tan L, Xing J, Wang Z, Du X, Luo R, Wang J, Zhao J, Zhao W, Yin C. Study of gray matter atrophy pattern with subcortical ischemic vascular disease-vascular cognitive impairment no dementia based on structural magnetic resonance imaging. Front Aging Neurosci. 2023;15:1051177. https:\/\/doi.org\/10.3389\/fnagi.2023.1051177.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1644_CR37","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","volume":"29","author":"M Jin","year":"2022","unstructured":"Jin M, Xu R, Wang L, Alam MM, Ma Z, Zhu S, et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease. Cell Stem Cell. 2022;29(7):1135\u201353. https:\/\/doi.org\/10.1016\/j.stem.2022.06.007. e8.doi:.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"1644_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/alz.13493","volume":"20","author":"SAI Sanford","year":"2024","unstructured":"Sanford SAI, Miller LVC, Vaysburd M, Keeling S, Tuck BJ, Clark J, et al. The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology. Alzheimers Dement. 2024;20(2):1013\u201325. https:\/\/doi.org\/10.1002\/alz.13493.","journal-title":"Alzheimers Dement"},{"key":"1644_CR39","doi-asserted-by":"publisher","unstructured":"Naguib S, Torres ER, Lopez-Lee C, Fan L, Bhagwat M, Norman K, et al. Gan. APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition. bioRxiv, 2024.https:\/\/doi.org\/10.1101\/2024.04.25.591140","DOI":"10.1101\/2024.04.25.591140"},{"issue":"9","key":"1644_CR40","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.chom.2021.07.004","volume":"29","author":"CA Olson","year":"2021","unstructured":"Olson CA, Iniguez AJ, Yang GE, Fang P, Pronovost GN, Jameson KG, et al. Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia. Cell Host Microbe. 2021;29(9):1378\u2013e13926. https:\/\/doi.org\/10.1016\/j.chom.2021.07.004.","journal-title":"Cell Host Microbe"},{"key":"1644_CR41","doi-asserted-by":"publisher","first-page":"1368doi","DOI":"10.3389\/fphar.2018.01368","volume":"9","author":"S Bolivar","year":"2018","unstructured":"Bolivar S, Anfossi R, Humeres C, Vivar R, Boza P, Munoz C, Pardo-Jimenez V, Olivares-Silva F. Diaz-Araya. IFN-beta Plays Both Pro- and Anti-inflammatory Roles in the Rat Cardiac Fibroblast Through Differential STAT Protein Activation. Front Pharmacol. 2018;9:1368doi. https:\/\/doi.org\/10.3389\/fphar.2018.01368.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1644_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1212\/WNL.0000000000000665","volume":"83","author":"A Singh-Manoux","year":"2014","unstructured":"Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, Kivimaki M. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology. 2014;83(6):486\u201393. https:\/\/doi.org\/10.1212\/WNL.0000000000000665.","journal-title":"Neurology"},{"key":"1644_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbi.2015.03.015","volume":"48","author":"AL Marsland","year":"2015","unstructured":"Marsland AL, Gianaros PJ, Kuan DC, Sheu LK, Krajina K, Manuck SB. Brain morphology links systemic inflammation to cognitive function in midlife adults. Brain Behav Immun. 2015;48:195\u2013204. https:\/\/doi.org\/10.1016\/j.bbi.2015.03.015.","journal-title":"Brain Behav Immun"},{"issue":"20","key":"1644_CR44","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1212\/WNL.0000000000201116","volume":"99","author":"T Kipinoinen","year":"2022","unstructured":"Kipinoinen T, Toppala S, Rinne JO, Viitanen MH, Jula AM, Ekblad LL. Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up. Neurology. 2022;99(20):e2294\u2013302. https:\/\/doi.org\/10.1212\/WNL.0000000000201116.","journal-title":"Neurology"},{"issue":"7","key":"1644_CR45","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","volume":"53","author":"S Kang","year":"2021","unstructured":"Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med. 2021;53(7):1116\u201323. https:\/\/doi.org\/10.1038\/s12276-021-00649-0.","journal-title":"Exp Mol Med"},{"issue":"10","key":"1644_CR46","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1212\/WNL.0b013e318248e50f","volume":"78","author":"CL Satizabal","year":"2012","unstructured":"Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3\u00a0C-Dijon Study. Neurology. 2012;78(10):720\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318248e50f.","journal-title":"Neurology"},{"issue":"17","key":"1644_CR47","doi-asserted-by":"publisher","first-page":"e1812","DOI":"10.1212\/WNL.0000000000207113","volume":"100","author":"EC Gertje","year":"2023","unstructured":"Gertje EC, Janelidze S, van Westen D, Cullen N, Stomrud E, Palmqvist S, Hansson O. Mattsson-Carlgren. Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia. Neurology. 2023;100(17):e1812\u201324. https:\/\/doi.org\/10.1212\/WNL.0000000000207113.","journal-title":"Neurology"},{"issue":"3","key":"1644_CR48","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11357-022-00556-w","volume":"44","author":"C Custodero","year":"2022","unstructured":"Custodero C, Ciavarella A, Panza F, Gnocchi D, Lenato GM, Lee J, Mazzocca A, Sabba C, Solfrizzi V. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis. Geroscience. 2022;44(3):1373\u201392. https:\/\/doi.org\/10.1007\/s11357-022-00556-w.","journal-title":"Geroscience"},{"issue":"9","key":"1644_CR49","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.neurobiolaging.2015.05.013","volume":"36","author":"M Schmitz","year":"2015","unstructured":"Schmitz M, Hermann P, Oikonomou P, Stoeck K, Ebert E, Poliakova T, Schmidt C, Llorens F, Zafar S. Zerr. Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy. Neurobiol Aging. 2015;36(9):2597\u2013606. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.05.013.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1644_CR50","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh SKL, Wolters FJ, Ikram MA, de Wolf F, Bos D, Hofman A. Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: A meta-analysis. Alzheimers Dement. 2018;14(11):1450\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.014.","journal-title":"Alzheimers Dement"},{"key":"1644_CR51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.bbi.2024.06.014","volume":"120","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhang J, Wu Y, Xie M, Tao S, Lv Q, Wang Q. Plasma IL-6 levels and their association with brain health and dementia risk: A population-based cohort study. Brain Behav Immun. 2024;120:430\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2024.06.014.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"1644_CR52","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30(9):1350\u201360. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.11.014.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1644_CR53","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11(1):5540. https:\/\/doi.org\/10.1038\/s41467-020-19264-0.","journal-title":"Nat Commun"},{"key":"1644_CR54","doi-asserted-by":"publisher","first-page":"102954doi","DOI":"10.1016\/j.ebiom.2020.102954","volume":"59","author":"AL Lumsden","year":"2020","unstructured":"Lumsden AL, Mulugeta A, Zhou A, Hypponen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59:102954doi. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102954.","journal-title":"EBioMedicine"},{"issue":"42","key":"1644_CR55","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1093\/eurheartj\/ehab249","volume":"42","author":"PT Pham","year":"2021","unstructured":"Pham PT, Fukuda D, Nishimoto S, Kim-Kaneyama JR, Lei XF, Takahashi Y, et al. Sata. STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases. Eur Heart J. 2021;42(42):4336\u201348. https:\/\/doi.org\/10.1093\/eurheartj\/ehab249.","journal-title":"Eur Heart J"},{"issue":"1","key":"1644_CR56","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1038\/s41467-022-32202-6","volume":"13","author":"K Poulakis","year":"2022","unstructured":"Poulakis K, Pereira JB, Muehlboeck JS, Wahlund LO, Smedby O, Volpe G, et al. Japanese Alzheimer\u2019s Disease Neuroimaging, B. Australian Imaging, and s. Lifestyle. Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer\u2019s disease. Nat Commun. 2022;13(1):4566. https:\/\/doi.org\/10.1038\/s41467-022-32202-6.","journal-title":"Nat Commun"},{"issue":"3","key":"1644_CR57","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41380-022-01878-z","volume":"28","author":"F Leng","year":"2023","unstructured":"Leng F, Hinz R, Gentleman S, Hampshire A, Dani M, Brooks DJ, Edison P. Neuroinflammation is independently associated with brain network dysfunction in Alzheimer\u2019s disease. Mol Psychiatry. 2023;28(3):1303\u201311. https:\/\/doi.org\/10.1038\/s41380-022-01878-z.","journal-title":"Mol Psychiatry"},{"issue":"15","key":"1644_CR58","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s40265-021-01604-z","volume":"81","author":"ED Deeks","year":"2021","unstructured":"Deeks ED, Anifrolumab. First Approval Drugs. 2021;81(15):1795\u2013802. https:\/\/doi.org\/10.1007\/s40265-021-01604-z.","journal-title":"First Approval Drugs"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01644-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01644-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01644-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T07:03:36Z","timestamp":1734764616000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01644-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01644-z","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of the USTC in Hefei, China (2019KY-26). All participants provided written informed consent for participating in the study. The Clinical Trial Number: (ChiCTR1900024777||) with the Clinical Trial Registry (July 27, 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}